AI-generated summary
The authors designed black phosphorus nanoagents loaded with the compound ginsenoside Rg3 and tested them in lung cancer models. They report that the nanoagents accumulated in primary and metastatic lung tumors and, with near-infrared light, produced combined chemo-photothermal effects. The study describes these results in vitro and in vivo, and reports good biocompatibility, but the abstract does not state sample sizes.
- Who or what was studied
- Lung cancer models, including primary tumors and lung metastasis (in vitro and in vivo; species and sample size not stated in the abstract)
- Limits stated in the abstract
- The abstract does not state sample sizes or animal numbers, and the findings come from in vitro and in vivo preclinical experiments rather than humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.